Skip to main content
TipRanks
Go Ultimate75% OFF

Sinopharm Group Co (SHTDF) Stock Forecast & Price Target

60 Followers
See the Price Targets and Ratings of:

SHTDF Analyst Ratings

Strong Buy
3Ratings
3Buy0Hold0Sell
Based on 3 analysts giving stock ratings to Sinopharm Group Co in the past 3 months

SHTDF Stock 12 Month Forecast

$2.67▲(31.60% Upside)
Based on 3 Wall Street analysts offering 12 month price targets for Sinopharm Group Co in the last 3 months. The average price target is $2.67 with a high forecast of $2.71 and a low forecast of $2.61. The average price target represents a 31.60% change from the last price of $2.03.
Highest Price Target$2.71Average Price Target$2.67Lowest Price Target$2.61

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for SHTDF
Price TargetArticle
Citi Analyst forecast on SHTDFUnknown AnalystNot RankedCiti$2.60→$2.61buy28.77%UpsideReiterated10/27/26
CICC Analyst forecast on SHTDFUnknown AnalystNot RankedCICC$3.15→$2.71buy33.48%UpsideReiterated10/27/26
CLSA Analyst forecast on SHTDFUnknown AnalystNot RankedCLSA$2.69buy32.54%UpsideReiterated08/25/26
Citic Securities Analyst forecast on SHTDFUnknown AnalystNot RankedCitic Securities$2.68buy31.91%UpsideReiterated07/01/26
Morgan Stanley Analyst forecast on SHTDFUnknown AnalystNot RankedMorgan Stanley$2.93buy44.48%UpsideReiterated05/14/26
UOB Kay Hian Analyst forecast on SHTDFUnknown AnalystNot RankedUOB Kay Hian$2.17hold6.79%UpsideReiterated04/28/26
First Shanghai Securities Analyst forecast on SHTDFUnknown AnalystNot RankedFirst Shanghai Securities$3.40buy67.72%UpsideReiterated04/04/26
Huatai Securities Analyst forecast on SHTDFUnknown AnalystNot RankedHuatai Securities$2.87buy41.52%UpsideReiterated03/24/26
Daiwa Analyst forecast on SHTDFUnknown AnalystNot RankedDaiwa$2.68buy31.91%UpsideReiterated03/24/26
UBS Analyst forecast on SHTDFUnknown AnalystNot RankedUBS$3.28buy61.44%UpsideReiterated03/23/26
Goldman Sachs Analyst forecast on SHTDFUnknown AnalystNot RankedGoldman Sachs$2.53hold24.56%UpsideReiterated03/23/26
HSBC Analyst forecast on SHTDFUnknown AnalystNot RankedHSBC$2.30→$2.49sell22.49%UpsideReiterated11/10/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PTGXProtagonist Therapeutics
ESTAEstablishment Labs Holdings
MDWDMediwound
IMUXImmunic
OVIDOvid Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Sinopharm Group Co

3 Months
Success Rate1/3 ratings generated profit
33%
Average Return
-3.97%

Copying Google Medical - Distribution's trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of -3.97% per trade.

1 Year
Success Rate1/3 ratings generated profit
33%
Average Return
-4.90%

Copying Google Medical - Distribution's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -4.90% per trade.

2 Years
Success Rate1/3 ratings generated profit
33%
Average Return
-4.90%

Copying Google Medical - Distribution's trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of -4.90% per trade.

SHTDF Analyst Recommendation Trends

05101520Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for SHTDF
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy00000
Buy35552
Hold00000
Sell00000
Strong Sell00000
total35552

In the current month, SHTDF has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. SHTDF average Analyst price target in the past 3 months is 2.67.

SHTDF Financial Forecast

$-1$-0.5$0$0.5$1Q4 2025Q2 2026Q4 2026
High$0.18
Consensus$0.17
Low$0.17

SHTDF Earnings Forecast

Next quarter’s earnings estimate for SHTDF is $0.17 with a range of $0.17 to $0.18. The previous quarter’s EPS was $0.10. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

$40.3B$41.1B$41.8B$42.5B$43.2BQ4 2025Q2 2026Q4 2026
High$43.2B
Consensus$43B
Low$42.8B

SHTDF Sales Forecast

Next quarter’s sales forecast for SHTDF is $42.98B with a range of $42.77B to $43.19B. The previous quarter’s sales results were $41.09B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

SHTDF Stock Forecast FAQ

What is SHTDF’s average 12-month price target, according to analysts?
Based on analyst ratings, Sinopharm Group Co’s 12-month average price target is $2.67.
What is SHTDF’s upside potential, based on the analysts’ average price target?
Sinopharm Group Co has 31.60% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is SHTDF a Buy, Sell or Hold?
Sinopharm Group Co has a consensus rating of Strong Buy which is based on 3 buy ratings, 0 hold ratings and 0 sell ratings.
What is Sinopharm Group Co’s price target?
The average price target for Sinopharm Group Co is $2.67. This is based on 3 12-month price targets, issued in the past 3 months. The highest analyst price target is $2.71, the lowest forecast is $2.61. The average price target represents a 31.60% increase from the current price of $2.03.
What do analysts say about Sinopharm Group Co?
Sinopharm Group Co’s analyst rating consensus is a Strong Buy. This is based on the ratings of 3 Wall Street analysts.
How can I buy shares of SHTDF?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.